Eledon Pharmaceuticals's total assets for Q3 2025 were $129.86M, a decrease of -10.39% from the previous quarter. ELDN total liabilities were $94.50M for the fiscal quarter, a 143.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.